Brief: Marksans Pharma Sept-Quarter Consol Net Profit 982.5 Million Rupees
13/11/2025 14:05
Marksans Pharma Ltd MARK.NS: MARKSANS PHARMA SEPT-QUARTER CONSOL NET PROFIT 982.5 MILLION RUPEES MARKSANS PHARMA SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 7.2 BILLION RUPEES Source text: ID:nBSE8bBTl2 Further company coverage: MARK.NS
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg